| Primer | Genus | LP | RP | Tml | Tmr | Length | Score | Target | Senstive |
|---|---|---|---|---|---|---|---|---|---|
| Primer 2021 | Thermobifida | ATCGTGGACGTGCAAGTCG | TGGAACGCGAAGATCTCCG | 60.73 | 59.86 | 260 | 57 |
100.00%
|
100.00%
|
| Primer 2022 | Thermobifida | TACGTCAAAGGCACCGTCG | TGACTTTCACCAGGTCGGC | 60.37 | 59.93 | 265 | 57 |
100.00%
|
100.00%
|
| Primer 2023 | Thermobifida | AAACGCAAGGAAGCAGCC | TCAGCACGATGATGGCCA | 58.96 | 59.01 | 256 | 57 |
100.00%
|
100.00%
|
| Primer 2024 | Thermobifida | TGTTCGCCAACATCGTGC | TCGATCATGGCGAGTTCCG | 59.06 | 59.93 | 268 | 57 |
100.00%
|
100.00%
|
| Primer 2025 | Thermobifida | TCTCAAACGCACCCCTGAC | TTTGACGAGCAGGGTGTCG | 59.93 | 60.30 | 238 | 57 |
100.00%
|
100.00%
|
| Primer 2026 | Thermobifida | TGACAGACTCGTGGCATCG | ACGAGTGGGGTGATCCAGT | 59.79 | 60.23 | 219 | 57 |
100.00%
|
100.00%
|
| Primer 2027 | Thermobifida | AGGTTCGGTTTGGCGACA | TACGCAACTGGTACGCCA | 59.49 | 58.95 | 153 | 57 |
100.00%
|
100.00%
|
| Primer 2028 | Thermobifida | AGGCGATGATGAACGGTCC | TGATGCGCACATGCTCCA | 59.86 | 60.05 | 159 | 57 |
100.00%
|
100.00%
|
| Primer 2029 | Thermobifida | CCGGAACTGTCGATGTCCA | ACCGATGAACGCACCCAT | 59.41 | 59.33 | 213 | 57 |
100.00%
|
100.00%
|
| Primer 2030 | Thermobifida | ACGATGCGGATGATCCTCG | AGAAACTGCCGATGCGCT | 59.71 | 60.05 | 259 | 57 |
100.00%
|
100.00%
|